Y
Ying A. Wang
Researcher at Novartis
Publications - 1
Citations - 126
Ying A. Wang is an academic researcher from Novartis. The author has contributed to research in topics: Lung cancer & Survival rate. The author has an hindex of 1, co-authored 1 publications receiving 115 citations.
Papers
More filters
Journal ArticleDOI
Safety and Efficacy of Buparlisib (BKM120) in Patients with PI3K Pathway-Activated Non-Small Cell Lung Cancer: Results from the Phase II BASALT-1 Study
Johan Vansteenkiste,Jean-Luc Canon,Filippo de Braud,Francesco Grossi,Tommaso De Pas,Jhanelle E. Gray,Wu Chou Su,Enriqueta Felip,Hiroshige Yoshioka,Cesare Gridelli,Grace K. Dy,Sumitra Thongprasert,Martin Reck,Paola Aimone,Gena Vidam,Pantelia Roussou,Ying A. Wang,Emmanuelle di Tomaso,Jean-Charles Soria +18 more
TL;DR: Despite preselecting patients for targeted treatment, the open-label, two-stage, Phase II study BASALT-1 did not meet its primary objective during Stage 1 and Combinations of PI3K inhibitors with other agents may demonstrate greater efficacy than monotherapy.